What Is the Success Rate of Autologous Stem Cell Transplant?
The use of autologous stem cell transplants is a kind of treatment that reconstructs or revitalizes diseased tissue with the use of a patient’s own stem cells. The opposite of this, though, is allogeneic transplantation, wherein stem cells are collected from the donors. Thus, the direct use of stem cells from the patient’s body excludes the possibility of the phenomenon of immune rejection which, in turn, makes autologous stem cell transplants more popular and potent. We will discuss the efficiency, process, and successful rate of autologous stem cell transplant and emphasize this blog about Global Regenex company being considered one of the best consultancy firms in the world doing stem cell therapy. What Is an Autologous Stem Cell Transplant? An autologous stem cell transplant is a procedure whereby cells from a patient can be taken, frozen, and later infused back into the patient in order to help repair the tissues and also augment the production of blood cells following intense treatments. These kinds of cells are, however very effective for treating diseases like lymphoma, leukemia, and multiple sclerosis, among others, because there will be regeneration and differentiation into other types of cells. This procedure helps those patients who receive high-dose chemotherapy or radiation treatment as these therapies tend to kill healthy bone marrow cells, necessary for the formation of blood cells. So, the reinfusion of stored healthy stem cells restores patients back to normal with fewer complications and allows their body’s immune system to start functioning normally. The Success Rate of Autologous Stem Cell Transplants The rate of success in the autologous stem cell transplant is variable, depending on many elements, including the patient’s condition, age, and overall health. In most cases, autologous stem cell transplants have significant success rates, primarily when treating blood-related cancers and multiple myeloma. These are the effectiveness and success rates for each condition. Lymphoma and Multiple Myeloma Scientific research has revealed that ASCT outcomes are much better than ever since it has led to remission in 50-70% of all the diagnosed patients with multiple myeloma and 40-60% of all the patients having other diagnoses. The improvement in the five-year survival rate of diagnosed multiple myeloma patients when autologous transplants are received has, on the other hand, been substantially prompted by the advancement that has been witnessed in stem cell technology and care support in the last ten years. Non-Hodgkin’s Lymphoma (NHL) These patients have also greatly benefited from autologous stem cell transplants, having up to 50% success rates in some studies. ASCT is definitely among the best treatments to induce remission in aggressive NHL. Autoimmune Diseases Although much rarer, ASCT is also used in the treatment of autoimmune diseases, including multiple sclerosis. For such diseases, ASCT can be useful to “reset” the immune system, an enormous hope for patients not responding to the standard treatments. The rates of success are encouraging in that several patients presented symptoms of regression and longer-lasting remissions. Degenerative Diseases Time-wise, autologous transplants are increasingly used to treat degenerative diseases like osteoarthritis and spinal cord injuries. Although clinical trials are still in progress, most patients have experienced improvements in their quality of life, reduced pain, and greater mobility following ASCT. The success rate may differ from patient to patient, research is continually being done on the long-term outcomes. Advantages of Autologous Stem Cell Transplants Lower Immune Rejection: Since the stem cells used are derived from the individual’s own body, the chances of immune complications are decreased. High Success Rate of Specific Diseases: Autologous stem cell transplant proves to be very effective with blood-related cancers and there is a high rate of cure for remission. Personalized Therapy: The patients are subjected to a therapy suited according to their specific health issues. Faster Recovery: Autologous stem cell transplant tends to reduce the time for recovery since it allows the body to recover healthy blood cells much faster. Long-Term Benefits: Patients tend to be in remission for more extended periods with improved quality of life after undergoing autologous stem cell transplant. Final Verdict With advancements in the technology of stem cells, the success rate of ASCT continues to improve and offers patients hope for a more extended remission and quality of life. Global Regenex offers trusted consultancy services to guide patients through the complexities of stem cell therapy and help them explore the best treatment options tailored for them. If you or a loved one is considering an autologous transplant, then consultation with Global Regenex may be a very useful step toward effective, customized care.
What Is the Cheapest Country for Stem Cell Therapy?
Stem cell therapy and the opportunity it offers to treat chronic diseases, injuries, and degenerative disorders using the regenerative power of the body to heal damaged tissues are significantly modifying the existing scientific comprehension of disease. Although many of these procedures are prohibitively expensive in most parts of the world, India has emerged as a leader in offering affordable high-quality stem cell therapy, including bone marrow transplant. This blog explains why India is the destination of choice for low-cost treatments and also how Global Regenex can help you in this journey. Understanding Stem Cell Therapy and Transplants This ability to develop into different types of cells is one of the characteristics making stem cells unique, promising a treatment approach for such conditions as spinal injuries, neurological disorders, and autoimmune diseases. A stem cell transplant of bone marrow is used when damaged or diseased cells are replaced with healthy, functional cells. It’s especially helpful in patients with cancers, blood disorders, and certain genetic conditions. Stem cell transplantation, also known as bone marrow transplantation, is the administration of cells to a recipient or from the recipient’s body to produce normal blood cells. It has become a widely used treatment for those that are afflicted with leukemia and lymphoma as well as many other diseases which affect the blood. Although versatility and high success rate have always made stem cell therapy highly desirable, in the United States and most of Europe, it is simply too expensive. Types of Stem Cell Treatments Offered in India India provides a range of stem cell therapies that are simple to complex treatments: Orthopedic Stem Cell Therapy It is applicable in conditions such as osteoarthritis, ligament injury, or degenerative disorders within the joints. The rehabilitation of joint mobility is orthopedic stem cell therapy that involves regenerating the damaged tissues and inflammation. Neurological Stem Cell Therapy This also includes repairing or replacing damaged neural cells, which might retard the progression of diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis in those affected. Bone Marrow Transplant The bone marrow transplant process in India is very successful in blood conditions like leukemia and lymphoma. It makes use of stem cells, and the cost is much lower than in other countries; this implies more number of patients can avail of these treatments. Stem Cell Therapy for Autoimmune Diseases The promising treatment has significantly improved the quality of life in patients whose pathophysiology is dominated by autoimmunity, for example, in many diseases like lupus and rheumatoid arthritis. Why India is the Most Affordable Country for Stem Cell Therapy? India has emerged as the best destination for economic healthcare, and stem cell therapy is no exception. Here are some key reasons why India stands as the best destination for individuals seeking affordable yet quality stem cell treatments: Lower Treatment Costs: There are different kinds of stem cell treatment available in India at much cheaper than in Western countries. World-Class Medical Facility: They have advanced health infrastructure with state-of-the-art technology and international accreditation. Highly Experienced Medical Professionals: Doctors have worldwide training experience and high success rates in stem cell procedures. Faster Access to Treatment: Shorter waiting times, especially useful in more urgent conditions. Comprehensive Patient Care and Support: India provides from consultation to follow-up, and offers translators and personalized care plans. Final Thoughts India has emerged as one of the centers that will provide inexpensive yet high-class stem cell therapy all around the world. Low-cost treatments along with high-class medical facilities along expert professionals ensure that the best results of advanced treatments are achieved in procedures like stem cell transplant and bone marrow transplants. Guidance from Global Regenex helps patients with intentions of stem cell therapy in selecting trusted medical professionals and facilities to ensure the safety and effectiveness of the treatment. Choosing India for life-altering medical care without breaking the bank may be the best decision.
What Are the Advantages of Stem Cell Therapy?
This is a promising, revolutionary medical treatment meant to bring hope to sufferers from chronic diseases or injuries. Indeed, such a treatment has the potential to slow or reverse the advancement of diseases by potentially reversing damage. A huge flexibility in stem cells has made some very great gains in treatments, including those through stem cell and bone marrow transplant. This option should be sought after with the help of consultancies such as Global Regenex by patients. Read through the many benefits of this therapy and how it’s changing the face of health care. What Are Stem Cells? These cells are the raw materials in the body, which through division and differentiation under suitable conditions, give rise to all other cells that assume a specialized function, like muscle, nerve, or blood cells. This property renders them invaluable for regenerative medicine, as they might replace or repair damaged tissues in various organs and systems. Stem cell therapy involves the application of stem cells or a product derived from stem cells directly into damaged tissue, with the objective of harnessing the regenerative power to help the body heal by restoring normal function. Classification of stem cells includes Adult Stem Cells: These are found in tissues like bone marrow and fat tissues, which help in the repair and regeneration of tissues. Induced Pluripotent Stem Cells (iPSCs): Made from adult cells, iPSCs can be differentiated into any cell type, even like embryonic stem cells. Benefits of Stem Cell Therapy Stem cell therapy offers several benefits in a wide range of medical conditions, hence ranking among the most versatile treatments in regenerative medicine. Potential to Treat Variety of Conditions There has been continued research into stem cell therapy for neurodegenerative diseases like Parkinson’s and Alzheimer’s, orthopedic injuries, cardiovascular diseases, and autoimmune disorders. Perhaps one of the most intriguing applications of stem cell transplants relates to treatments of diseases associated with blood, such as leukemia, lymphoma, and any kind of cancer. Enhanced Healing & Tissue Regeneration Stem cells might differ in the type of cells needed for restoration to any site of damage or degeneration. When delivered at the site of damage or degeneration, then stem cells can quicken restoration by the body. For instance, the MSCs were shown to reduce inflammation and assist in promoting restoration within damaged tissues, especially within conditions such as arthritis or even injury to the joint. Patients will feel immense pain relief plus very significant mobility following the procedure for their treatment using the application of stem cell therapy upon the joints and cartilage. Reduce Need for Invasive Procedures Alternative treatment by means of using stem cell therapy for some patients could well be far from a surgical intervention concerning the problem of health ailments that need treatment. These patients who could have otherwise used knee or hip replacements may owe tremendous relief due to injections containing stem cells. Patients who opt for stem cell therapy may escape the long recovery periods potential complications and high prices that accompany surgery. Potential to Overcome Organ Transplant Shortages Organ transplants are currently in a shortage because demand is more than supply, and thousands of patients are on waiting lists for life-saving procedures. Stem cells can regrow tissues and promise to even create organs inside the lab, which may become part of the solution toward possible uses. This area remains still largely experimental, and the recent advancements in stem cell therapies will eventually pave their own paths for patients looking for such a transplant. Organ transplant risks are removed significantly with this approach because, since the cells derived in such an approach can originate in a patient’s own body or tissue, they completely adapt to the body. Treating Cancer with Bone Marrow Transplantation A form of stem cell transplant utilized to treat leukemia, lymphoma, and other blood-related cancers is a bone marrow transplant. It is a medical treatment that replaces the patients’ damaged or destroyed bone marrow with healthy stem cells, thereby allowing them to rebuild their blood and immune cells, which would ultimately help them fight cancer aggressively. The Bottom Line New hope in combating diseases with no cure is now offered by advancements in healthcare through the therapy involving stem cells. This may be through efficient repair of tissues, reduced need for surgical intervention, and potential capability to treat cancer. It may be a stem cell or bone marrow transplant, and patients can find the right consultancy to work with so they can get the best options and comprehensive support on this journey. The future of regenerative medicine is bright, and stem cell therapy leads the way, offering hope and healing to countless people worldwide. To learn more about stem cell therapy consult with our regenerative medicine expert at Global Regenex.
Parkinson’s Disease
Disease: Parkinson’s Presenting Illness: A 62 year old male patient, Known case… Read More November 22, 2024 Parkinson’s Disease Angela From UK Came India for Stem Cell Treatment of Parkinson’s Disease Angela, my 59-year-old mother from UK showed the symptoms of… Read More November 22, 2024 Parkinson’s Disease Phil Came to India for Treatment of Parkinson’s Disease Just about 7-8 years ago, the neurologist at the hospital… Read More November 22, 2024 Parkinson’s Disease Charles Stemen from Australia Came India for Stem Cell Treatment of Parkinson’s Disease Charles Stemen from Australia came to India for his mother’s… Read More November 22, 2024 Parkinson’s Disease Azhar Visited India for Getting Stem Cell Parkinson’s Disease Treatment I am Azhar and some years ago, in 2001, I… Read More November 22, 2024 Parkinson’s Disease Mr. Thomas Jones from USA – Parkinson Patient Story Mr. Thomas Jones 60 years old suffering from Parkinson Disease… Read More November 22, 2024 Parkinson’s Disease Janet from Dubai came to india for stem cell treatment of Parkinson’s disease I am Janet and until few months, was a sufferer… Read More November 22, 2024 Parkinson’s Disease Load More
Stem Cell Treatment Patient Stories
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Stella from Brazil Came India for Stem Cell Treatment for ALS Stella, a 48-year-old patient from the Brazil, got stem cell… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Julie From United States Came India for Stem Cell Treatment of Amyotrophic Lateral Sclerosis Julie was diagnosed with ALS while in the United States…. Read More November 22, 2024 Amyotrophic Lateral Sclerosis Mr. Angad from Norway Came to India for the Treatment of ALS 57 year old, Mr. Angad was a nobleman and had… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Jossie from Australia Came India for Stem Cell Treatment for ALS Jossie, 34 from Australia was detected with ALS. She tried… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Noah Woods, 47 year old American Came India for Stem Cell Treatment of Amyotrophic Lateral Sclerosis Noah Woods, a 47-year-old American patient was spotted with Amyotrophic… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Noah Woods, 47 year old American Came India for Stem Cell Treatment of Amyotrophic Lateral Sclerosis Noah Woods, a 47-year-old American patient was spotted with Amyotrophic… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Mr. Bilal from Pakistan Came to India for ALS Treatment Mr. Bilal, 62 years from Peshawar Pakistan was a healthy… Read More November 22, 2024 Amyotrophic Lateral Sclerosis Paul from USA came to india for stem cell treatment of ALS My father, Mr. Steve Mathews was suffering from ALS disorder…. Read More November 22, 2024 Amyotrophic Lateral Sclerosis Load More Categories Amyotrophic Lateral Sclerosis (8) Autoimmune Disease (1) Autologous Stem Cell Transplant (1) Blog (9) Bone Marrow Transplants (3) Brain Injury (1) Diabetes (1) Immunotherapy (4) Knee Injuries (1) Lymphoma (1) Osteoarthritis (1) Parkinson’s Disease (7) Stem Cell Therapy (2) Stem cell treatment (4) Stem Cell Treatment Patient Stories (2) Recent Posts
Parkinson’s Disease
Overview Symptoms Types Causes Diagnosis Treatment Procedure Implantation FAQ Improvements Mechanism Our Promise Cost Success Rate Advantages Quality Control Treatment Results Testimonials Quality Certificate Follow up Trеatmеnt Disclaimеr Parkinson’s disease happens when there is a problem with certain nerve cells in the brain. This disease affects the way you move because of inadequate production of dopamine, which is an important chemical that sends signals to the part of the brain that controls movement. Parkinson’s is a progressive disease whose symptoms take few years to surface. Parkinson’s is an illness that affects the central nervous system with a direct blow on the brain, and spinal cord and usually only affects adults. More specifically, this disease damages a group of nerve cells in the deepest part of the brain called the Basal Ganglia. There are quiet a few reasons leading to Parkinson’s disease, including aging and poisons in the environment. To cure Parkinson’s disease, stem cell treatment is highly popular. These nerve cells make and use a brain chemical called dopamine to send messages to other parts of the brain to coordinate body movements. When someone suffers from Parkinson’s disease, the dopamine levels are low. So, the body doesn’t get the right messages required to move normally. About 1 million people in the United States alone have Parkinson’s, and both men and women can be affected by it. It usually affects the elderly population someone older than 50 and it becomes common as people get older. Many people wonder if you’re more likely to inherit the Parkinson’s disease due to hereditary or not. The role that heredity plays isn’t completely understood, however, if someone has a close relative with Parkinson’s the chances of developing the disease becomes very high. But Parkinson’s disease is not transmittable. You can’t get it by simply being around someone who has it. An effective Parkinson’s disease stem cell treatment in Delhi, India that StemCellCareIndia offers can prove to be a boon for you. The four main symptoms of Parkinson’s are: Slow movement Problems with balance or walking Stiff muscles Tremor, which essentially means shaking or trembling. Tremor may affect your hands, arms, or legs. The symptoms of Parkinson’s disease include tremors or trembling (shaking hands are often the most telltale signs of Parkinson’s, including difficulty in maintaining balance and coordination; trouble standing or walking; stiffness; and general loss in swiftness. Over the years, a person with Parkinson’s may have trouble smiling, talking, or swallowing. Their faces may appear flat and expression less, but people with Parkinson’s have feelings – even though their faces don’t always show it. Sometimes people with the disease can have trouble with thinking and remembering, too. Stem cell treatment for Parkinson’s is quiet popular and effective. Because of problems with balance, some people with Parkinson’s frequently loose balance and fall, which can result in broken bones. Some people with Parkinson’s may also feel sad or depressed and lose interest in the things they used to do. The symptoms of Parkinson’s disease appear gradually and get worse over time. But because Parkinson’s disease usually develops slowly, most people who suffer from it can live a long and relatively healthy life. Parkinson’ disease stem cell treatment in India is popular and trusted. Parkinson’s disease is a condition that makes it difficult to control one’s movement and get things done. It can be challenging because of its progressive nature and its challenges. It’s thought to affect about 1% of the population over 65 years of age. Parkinson’s disease (PD) has several forms, including the following: Idiopathic Parkinson’s disease: Idiopathic Parkinson’s disease is the most common type of this chronic movement disorder, an illness that usually affects older individuals, with an average age of onset around 60 and its causes are unknown, generally assumed to be a mix of genetic and environmental factors. Juvenile and early-onset Parkinson’s disease: These two forms are considerably similar to each other with the only difference being the age difference. Juvenile PD affects people before the age of 21 while people between 21 and 40 when diagnosed are stated as those affected by Early-onset or young-onset PD. This form of PD is rare and has similar symptoms to that of Idiopathic PD with the difference that it has a slow progressive rate and its symptoms are a bit more extreme due to the patient being in the prime of his/her life. Multiple system atrophy: It is a neurodegenerative disease resulting from the loss of nerve cells involved in regulating movement and the autonomic nervous system. MSA is characterized by the presence of clumps of alpha-synuclein protein in glial cells and not nerve cells. In most cases of MSA, people experience problems with speech and sleep as well as uncoordinated movements that progressively worsen as time goes on. These symptoms typically appear at around the age of 50. Progressive Supranuclear Palsy (PSP): Progressive supranuclear palsy, also called Steele-Richardson-Olszewski syndrome, is an uncommon parkinsonian syndrome. It can be seen manifesting in adults over the age of 50. It progresses much more rapidly than Idiopathic Parkinson’s and shows specific signs like rigidity, bradykinesia (slow movements), and postural instability. The differences between PSP and Idiopathic PD are based on their supranuclear involvement in the cortical brain regions related to coordination of movement, and sequencing activities in the central nervous system to initiate proper muscle movement. Drug-induced Parkinson’s: Drug-induced Parkinsonism is the second most common cause of Parkinsonism. It can occur when a drug interferes with dopamine transmission in your body. The risk of getting it increases as you age. According to research published in Movement Disorders, researchers found the average age of onset for drug-induced Parkinsonism was 70. Corticobasal syndrome: It is also one of the rare types of Parkinson’s disease and it is the result of the build-up of Tau, a type of protein in one’s brain. Its symptoms could be muscle stiffness, improper limb control on one side of the body, tremors, slow or slurry speech, dementia, swallowing issues, etc. Vascular Parkinson’s: Vascular Parkinsonism occurs when small strokes make
Amyotrophic Lateral Sclerosis
Overview Symptoms Types Causes Diagnosis Treatment Procedure Implantation FAQ Improvements Mechanism Our Promise Cost Success Rate Advantages Quality Control Treatment Results Testimonials Quality Certificate Follow up Trеatmеnt Disclaimеr Amyotrophic Lateral Sclerosis (ALS), often called Lou Gehrig’s disease after the renowned baseball player’s struggle with this disease and later died of the same in 1941 grabbed national attention. It is an incurable, progressive degenerative neurological disorder. The nerve cells of the brain and spinal cord that controls the voluntary muscle movement gradually decline for no apparent reasons. The muscles waste away, leading to paralysis and death of the person in 2-5 years’ time. The only neurons affected are the lower motor nerve cells which control a wide range of things like movement of limbs, swallowing, and even breathing. There are ALS treatment centers in India, who specialize in providing the best treatment to cure the disease. Motor neurons run from brain to the spinal cord and from the spinal cord to the muscles throughout the body. The progressive degeneration of the motor neurons eventually leads to their death. When motor neurons die, the ability of the brain to start and control muscle movement is lost. This also affects a person’s ability to speak, eat, move and breathe. In ALS, the motor neurons that provide voluntary movements and muscle control are affected. Research has revealed a wealth of new scientific understanding about the physiology of this disease. Stem cell treatment for Amyotrophic Lateral Sclerosis has emerged as an effective treatment option for ALS. Do you Know about Amyotrophic Lateral Sclerosis? ALS (Amyotrophic lateral sclerosis), which is characterised by muscle weakness and the appearance of ALS can also be caused by mutations in the TSC1 gene This disease also involves nerve cells in the brain and spinal cord, with the possible progression affecting the motor neurons. Neurons provide the urge or prompt to activate the desired muscle in ALS. Walking, for example, is not a complex signal to do so there is no action of the voluntary muscles necessary. This is deadly if not treated. It is four or five years on average, but in rare circumstances, it can be as long as seven years. but due to the recent advancements of medical science, a breakthrough in care for ALS occurred because stem cell therapies are not as safe as they used to be ( regeneration of affected portion of the brain ). The beginning of ALS may be so blurred which causes the symptoms to be frequently ignored. The earliest symptoms may include: Slurred and nasal speech Difficulty chewing or swallowing Muscle weakness affecting an arm or a leg Spasms, cramps, or stiffness of muscle Depending on the muscles in the body that are damaged first the early symptoms of ALS surface. Symptoms initially affect one of the legs and patients experience difficulty in running or walking, or they experience sudden stumbling or tripping more often. The signs of this disease first appear on the hands or arms and they experience difficulty in pursuing simple tasks requiring manual agility such as writing, turning a key in a lock and other. Some patients notice speech problems as well. ALS affects the upper motor neurons, which are in the brain, and the lower motor neurons, which are in the spinal cord and brainstem. Upper motor neuron degeneration generally causes spasticity (tightness in a muscle), while the lower motor neuron degeneration causes muscle weakness, muscle atrophy (shrinkage of muscles) and twitching. These can occur in combination to ALS, as upper and lower motor neurons can be lost at the same time. Though it usually strikes people in their late middle age, ALS can affect the people of any age. It is characterized by persistent weakness or spasticity in an arm or leg. The problem originated in the muscles incorporating controlling speech or swallowing. People facing such issues cannot ignore the problem and must see a doctor. Amyotrophic Lateral Sclerosis (ALS) is generally characterized in two variants, depending on its origin. These types are mentioned below: Sporadic Amyotrophic Lateral Sclerosis: This is the primary type of ALS, affecting up to 95% of ALS cases. The origin of this type of ALS is believed to be random, having no specific cause or relation to any previous genetic condition. Familial Amyotrophic Lateral Sclerosis: This variant of ALS runs in the family and is pretty rare, with only 5-10% of the total ALS cases falling under its characteristics. In this type, ALS spreads genetically, i.e., passing down from the affected parent to the children at birth with a chance of 50%. ALS can be inherited in 5 to ten% cases, at the same time as the others don’t have any known cause. Other viable reasons are being investigated. Gene mutation or other genetic causes are underneath investigation, howeversome different instances showcase no genetic link. To diagnose ALS, a neurologist will administer electromyogram (EMG) for the detection of nerve damage. Electromyogram (EMG) Nerve conduction study Magnetic resonance imaging (MRI) Blood and urine tests Spinal tap (lumbar puncture) Muscle biopsy Latest researches have revealed that MSCs can help restore Myelin of nervous system, improving symptoms and prolonging lives. Steroids and other disease modifying drugs cannot cover all the symptoms and are aimed to manage only specific symptoms. Again, the concern of critical side effects of drugs is also there. With MSC treatment, there is no such concern. Day 1- Pick up from the Airport to the Hospital Interaction between Dr and Patient, to clear all their doubts at that time Admission procedure Clinical examination & Lab test will be done prescribed by the doctor Supportive Therapy Day 2- Stem cell Procedure Supportive therapies Physiotherapy Day 3- Supportive Therapy Physiotherapy Discharging formalities Drop back to the Airport Note: For Admission, carry the identity card (Passport/ Pan Card / Driving License) Carry the hard copy of Patient reports ALS can be inherited in 5 to ten% cases, at the same time as the others don’t have any known cause. Other viable reasons are being investigated. Gene mutation or other genetic causes are underneath investigation, howeversome different instances showcase no genetic link. 01. What Is ALS? ALS is the sickness poignant in which the brain cells popularly referred to as neurons connecting the brain with alternative elements of the body, act as messengers
Mr. Jeet Gupta – Bilateral Osteo-Arthritis (OA) Knee
Summary Diagnosis Sex Age Bilateral Osteo-Arthritis (OA) Knee Male 43 Nationality Admission date Discharge date Indian October 16, 2023 October 18, 2023 DIAGNOSIS: Bilateral Osteo-Arthritis (OA) Knee. CHIEF COMPLAINT: known case of bilateral OA knee, more pain in right knee compared with left knee. Patient has generalised nee pain and his overall wellness is fine. PRESENTING ILLNESS: A 43 years old male presented with history of pain in bilateral knee joints. His left knee pain has mostly recovered, but his Right knee pain still has its problem in knee joint. He can do regular exercise but feel some pain all the time. Currently he has pain on lower right part of the right knee. Conservative medicinal treatment is going on. Patient overall health is good. Now patient has come to us for the experimental stem cell therapy for his OA knee and overall immunity booster. We have taken written consent for doing this experimental stem cell therapy. PAST MEDICAL HISTORY: Patient has h/o Knee joint pains in past too. He has taken stem cell Rx for the same in 2022. Later on he has got recovered from his knee pain in left side but right knee still give some pain. Also patient has past h/o Covid 19 infection twice since its inception. He has taken covid vaccination (Pfizer) sot for the prevention of covid 19, but still sometime he feels having cough which doesn’t go quickly. FAMILY HISTORY: No h/o major illness in family. ON EXAMINATION: conscious and well-oriented B: P: 130/80 mm of Hg Pulse: 80 b/m Temp.: 98.6o F RR: 22 SpO2: 98% INVESTIGATION: All report attached with discharge summery card. PLAN OF ACTION: UC-MSC cellular therapy Bilateral intra-articular injection of MSCs. Exosome Inj MVI injections Inj Vitamin C Inj Monocef 1gm & In Pan40mg OPERATION UNDER TAKEN / PROCEDURE: Umbilical cord derived Mesenchymal stem cells 100 Million + Exosome (50µgm) growth proteins given through intravenous route. Bilateral intra-articular injection of MSCs (60millions) + Exosome protein (50µgm) given in both knee joint spaces by orthopedician with NO any adverse event. MVI injection (5cc) given in 100cc NS for 1 hrs slow infusion. Inj Monocef 1gm stat & Inj Pan40mg stat Vitamin C in 100cc NS given slowly. IN COURSE OF HOSPITAL AND COMPLICATION IF ANY: Patient was clinically examined and thoroughly investigated, physician opinion taken and informed written consent taken. On day 1st, patient’s history presenting illness was taken. He has feeling of some bodyache and internal feverishness due to some past viral flu. All necessary blood investigation, chest x-ray and ECG were done. He has been started with inj Paracetamol 1gm stat dose. Post procedure was uneventful (no headache or vomiting). All vitals settled down with GC stable. Patient was afebrile, conscious and well oriented. During post lunch time, patient was given 5cc of Inj MVI via 100cc NS for an hour. On day 2nd, Patient’s bodyache and feverish feeling was settled down normal and he was feeling better and energetic. Now patient has been given as precautionary dose of inj Monocef 1gm & inj Pan 40mg as stat dose. Then he was given Inj Vit C via 100cc NS slowly. Patient was taken in OT and under sterile OT environment, 30M UC-MSCs + exosome was administered into intra-articular spaces of each knee joint. The intra-articular inj was administered by orthopedician, by taking aseptic precautions. Post procedure was uneventful (no headache or vomiting). All vitals settled down with GC stable. Patient was afebrile, conscious and well oriented. During post lunch time, he was also given UC-MSCs (100M) + Exosome protein (50µgm) via 100cc NS. Post procedure was uneventful. On day 3rd, at time of discharge he is clinically stable. Fever and bodyache also settled down. He has been advised to take proper and regular medications for his low Hb. AT THE TIME OF DISCHARGE: B: P: 130/80 mm of Hg Pulse: 75 b/m Temp.: 98.6 F RR: 22 Spo2: 98% DISCHARGE MEDICATION: Boslin….OD…. for 3 months. Omega3 … OD…after Lunch & Dinner… for 3 months. Zincovit…Daily once… for 3 months. NOTE: Kindly visit to nearby Hospital emergency ward, if you observe HTN, fever, headache, seizures, severe vomiting, severe abdominal discomfort and decreased appetite. Contact us at scci@gmail.com, what’s app No: +91 78382 23336 SIGNATURE AND STAMP OF DOCTOR / AUTHORITY DEPARTMENT
Mr. Parmanand Tulsyan – Retinitis Pigmentosa
Summary Diagnosis Sex Age Retinitis Pigmentosa Male 44 Nationality Admission date Discharge date Indian May 25, 2023 June 26, 2023 DIAGNOSIS: Retinitis Pigmentosa. CHIEF COMPLAINT: Patient is known case of retinitis Pigmentosa. He has been observed for visual impairment since 2008. He has c/o poor vision in both eyes initially since 2004-2005 but it appeared to be worse in 2008. Vision in daylight is good but its difficult vision in both eyes at night/darkness. Central vision is good as of now but peripheral vision is affected in both eyes. Due to dimness of vision, he has inability to read, glare at night/darkness. PRESENTING ILLNESS: A 44 years old male presented with history of difficulties of vision in both eyes since 2008. But initially his vision in both eyes was normal with good day vision till 2004-2005. Later on he developed difficulties in both eyes during night vision/darkness. He has got loss of vision in both eyes during night time and unable to figure out object and colours in darkness. His central vision is good with poor vision in peripheral region. Patient’s overall health is good but his eyesight is not so good. PAST MEDICAL HISTORY: He has h/o covid-19 infection in 2021 and got recovered from the same. Also he has taken 2 covaxin doses. FAMILY HISTORY: h/o RP in elder brother. ON EXAMINATION: conscious and well-oriented B: P: 130/90 mm of Hg Pulse: 78 b/m Temp.: 98.6o F RR: 22 SpO2: 96% INVESTIGATION: All blood reports, ECG reports, chest X-ray report attached with discharge summery. PLAN OF ACTION: UC-MSC cellular therapy Bilateral Retro bulbar injection of MSCs. Exosome Inj MVI injections Inj Vit C monocef 1gm & Inj. Pan40mg OPERATION UNDER TAKEN / PROCEDURE: Umbilical cord derived Mesenchymal stem cells (100Millions) + Exosome growth proteins (50µgm) given through intravenous route. Bilateral Retro bulbar injection of MSCs (30M each eye) + Exosome protein (50µgm) given in both eye under LA by Ophthalmologist with NO any adverse event. MVI injection given in 100cc NS for 1 hrs slow infusion. monocef-o 1gm & Inj Pan 40mg –IV / stat Vit C injection given in 100cc NS for 1 hrs slow infusion. IN COURSE OF HOSPITAL AND COMPLICATION IF ANY: Patient was clinically examined and thoroughly investigated, physician opinion taken and informed written consent taken. After examination, his GC was stable and he was afebrile. On day 1st, he was given inj.monocef-O 1gm & inj. Pan 40mg stat, IV dose. Later in afternoon, he was taken to OT for retroblubar stem cell procedure. Under LA, retroblubar inj of 30millions UC-MSCs + Exosome (50µgm) was given in both eyes by Ophthalmologist. Post procedure was uneventful (no headache or vomiting). Slight pain at inj site was present in both eyes, for which eye drop has been administered once. He was given I/v MSCs (100millions) cells + Exosome (50µgm) by taking aseptic precautions. Post procedure was uneventful. At evening, later on Patient was stable & well oriented. On day 2nd, GC is stable and afebrile. There was no pain in both eyes and no headache. He was given 5cc Inj of MVI via 100cc NS slowly. Later on he was given Inj Vit C via 100cc NS slowly. now at time of discharge he is clinically stable. AT THE TIME OF DISCHARGE: B: P: 120/80 mm of Hg Pulse: 72b/m Temp.: 98.6 F RR: 22 Spo2: 99% DISCHARGE MEDICATION: Ophthacare eye Drops….OD for 3 months. Boslin….OD…. for 3 months. NOTE: Kindly visit nearby Ophthalmologist for retinal evaluation after 3 months. Kindly visit to nearby Hospital emergency ward, if you observe fever, headache, seizures, severe vomiting, severe abdominal discomfort and decreased appetite. SIGNATURE AND STAMP OF DOCTOR / AUTHORITY DEPARTMENT All reports received by, ——————————————–, patient/attendant, dated on 26/06/2023
